Status:
TERMINATED
Efficacy & Tolerability of Rigth Unilateral vs. Bitemporal ECT in Schizophrenia in a Psychiatric Hospital in Mexico
Lead Sponsor:
Hospital Psiquiátrico Fray Bernardino Álvarez
Conditions:
Schizophrenia Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Electroconvulsive therapy (ECT) is an established treatment for medication-resistant schizophrenia. There is debate about the best method of electrode placement. Bitemporal (BT) placement is commonly ...
Detailed Description
Study Design and Setting: Randomized experimental trial at Fray Bernardino Álvarez Psychiatric Hospital, Mexico City. Sample Size: Quota sampling. Eligibility Criteria: inpatients, spanish-speaking, ...
Eligibility Criteria
Inclusion
- A)
- Spanish-speaking.
- any sex/gender.
- Aged ≥18 years.
- 3\. Diagnosis of schizophrenia per DSM-5 criteria. 4. Baseline PANSS (Positive and Negative Syndrome Scale) total score ≥60. 5. Treatment with 1-2 antipsychotics (including clozapine).
- B)
Exclusion
- Received ECT (electroconvulsive therapy) within the previous 3 months.
- Comorbid affective disorders (e.g., bipolar disorder, major depressive disorder).
- Catatonia or catatonic syndrome.
- Pregnancy
- Contraindications to general anesthesia/ECT (i.e. uncontrolled cardiovascular disease or intracranial hypertension).
Key Trial Info
Start Date :
March 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2024
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06972745
Start Date
March 16 2023
End Date
November 16 2024
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Psiquiátrico Fray Bernardino Álvarez
México, Mexico